Prescription of a THC/CBD-Based Medication to Patients with Dementia : A Pilot Study in Geneva

Article Article scientifique Article Prescription of a THC/CBD-Based Medication to Patients with Dementia : A Pilot Study in Geneva eng 2019 author Broers Barbara 28005 author Pata Zacharie 828972 author Mina Aline 782733 author Wampflert James author De Saussure Christian 30377 author Pautex Sophie Marie 37604 56-59 10.1159/000498924 2504-3889 https://www.karger.com/Article/Fulltext/498924 Dementia is increasing worldwide. No effective medication is currently available for the treatment of the underlying disease and accompanying behavioral symptoms. Cannabinoids might have a beneficial effect, but clinical studies with (low-dose) synthetic THC have not been conclusive. Objective: To test the acceptability, practical aspects, and clinical outcomes of the introduction of a THC/CBD-based oral medication in severely demented patients in a specialized nursing home in Geneva. Cannabinoids Dementia Treatment THC/CBD Dewey 613 Dewey 618.97 64 Département de santé et médecine communautaires 22A 65 Département de réadaptation et gériatrie 22B false 100 Médecine de l'addiction 129 436 Médecine palliative 709 Medical Cannabis and Cannabinoids 2 798767f7-d8e5-4a21-b641-5439b2acb0da Article (Published version) Public document(17).pdf 145746 application/pdf CC BY-NC-ND openAccess Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires Faculté de médecine / Section de médecine clinique / Département de réadaptation et gériatrie

Title	Published in	Access level	OA Policy	Year	Views	Downloads

Prescription of a THC/CBD-Based Medication to Patients with Dementia : A Pilot Study in Geneva	Medical Cannabis and Cannabinoids			2019	422	129

Archive ouverte UNIGE

Mina, Aline